The Recall Desk

Hazard

Particulate Matter recalls

410 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.

What the numbers show

Total
410
Critical
57
Severe
186
Most recent
2026-09-02

Of the 410 particulate matter recalls we have scored against our rubric, 57 (14%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 186 (45%) are Severe.

Which agencies issued them

About this hazard tag

Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all particulate matter recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.

A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.

351–375 of 410

  • SevereFDA (Drugs)·D-1266-2014·2014-05-07

    B. Braun Recalls Ceftriaxone Injection Due to Particulate Matter

    B. Braun Medical Inc. is recalling Ceftriaxone for Injection and Dextrose Injection due to visible particulate matter found in reserve sample units.

    Product
    Ceftriaxone for Injection and Dextrose Injection, 1 g in Duplex, 50 mL Container, Catalog Number 3153-11, For IV Use Only, Single Dose, Sterile, Rx Only, B Braun Medical Inc., Irvine CA 92614-5895
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1264-2014·2014-05-07

    B. Braun Recalls Cefoxitin and Dextrose Injectable Due to Particulate Matter

    B. Braun Medical Inc. is recalling Cefoxitin and Dextrose injectable products due to visible particulate matter found in reserve sample units.

    Product
    CEFOXITIN AND DEXTROSE — CEFOXITIN AND DEXTROSE (CEFOXITIN SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1282-2014·2014-05-07

    Baxter Recalls 0.9% Sodium Chloride Irrigation Due to Nylon Fibers

    Baxter Healthcare Corp. is recalling 211,752 bottles of 0.9% Sodium Chloride Irrigation, USP, 1000 mL, due to the presence of nylon fibers.

    Product
    SODIUM CHLORIDE — SODIUM CHLORIDE (SODIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1251-2014·2014-04-30

    Shire Recalls VPRIV Vials Due to Presence of Particulate Matter

    Shire Human Genetic Therapies is recalling 8,359 vials of VPRIV (velaglucerase alfa) because they contain stainless steel and barium sulfate particles.

    Product
    VPRIV — VPRIV (VELAGLUCERASE ALFA)
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1234-2014·2014-04-23

    Hospira Recalls Lidocaine Hydrochloride Injection Due to Particulate Matter

    Hospira, Inc. is recalling 1% Lidocaine Hydrochloride Injection vials because oxidized stainless steel was found in the product.

    Product
    LIDOCAINE HYDROCHLORIDE — LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1225-2014·2014-04-16

    Agila Recalls Etomidate Injection Due to Particulate Matter and Labeling Issues

    Agila Specialties Private Ltd. is recalling etomidate injection vials due to potential particulate matter and missing or illegible lot and expiry date labels.

    Product
    etomidate injection, USP, 2 mg/mL, packaged in a) 20 mg/10 mL (2 mg/mL), 10 mL Single Dose Vials (NDC 0069-0006-02), 10 x 10 mL vials per carton (NDC 0069-0006-01) and b) 40 mg/20 mL (2 mg/mL) 20 mL Single Dose Vials (NDC 0069-0006-04), 10 x 20 mL vials per carton (NDC 0069-0006-
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1163-2014·2014-03-26

    Baxter Recalls Sodium Chloride IV Solutions Due to Particulate Matter

    Baxter Healthcare is voluntarily recalling 0.9% Sodium Chloride Injection IV solutions due to the presence of particulate matter, including fibers and plastic particles.

    Product
    SODIUM CHLORIDE — SODIUM CHLORIDE (SODIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1160-2014·2014-03-26

    Baxter Recalls Clinimix IV Bags Due to Particulate Matter

    Baxter Healthcare is recalling 7,388 bags of Clinimix 5/15 sulfite-free IV solution because they contain particulate matter, including wood, sodium citrate, and dextrose.

    Product
    CLINIMIX — CLINIMIX (LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DEXTROSE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1158-2014·2014-03-26

    Baxter Recalls Clinimix E Bags Due to Particulate Matter

    Baxter Healthcare is recalling 14,574 bags of Clinimix E IV solution found to contain particulate matter, including wood, sodium citrate, and dextrose.

    Product
    CLINIMIX E — CLINIMIX E (LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DIBASIC POTASSIUM PHOSPHATE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, DEXTROSE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1161-2014·2014-03-26

    Hospira Recalls Marcaine Injection Vials Due to Metal Particulate Matter

    Hospira is recalling 40,360 vials of Marcaine (bupivacaine hydrochloride) injection because some units contain visible metal particles that discolor the solution.

    Product
    MARCAINE — MARCAINE (BUPIVACAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1159-2014·2014-03-26

    Baxter Recalls Clinimix E IV Bags Due to Particulate Matter

    Baxter Healthcare is recalling 7,068 bags of Clinimix E IV solution because they contain particulate matter, including wood, sodium citrate, and dextrose.

    Product
    CLINIMIX E — CLINIMIX E (LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DIBASIC POTASSIUM PHOSPHATE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, DEXTROSE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1162-2014·2014-03-26

    Baxter Recalls 5% Dextrose Injection Due to Particulate Matter

    Baxter Healthcare is voluntarily recalling 105,216 containers of 5% Dextrose Injection due to the presence of particulate matter, including fibers and plastic particles.

    Product
    DEXTROSE — DEXTROSE (DEXTROSE MONOHYDRATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1168-2014·2014-03-26

    Perrigo Recalls Clindamycin Oral Solution Due to Particulate Matter

    Paddock Laboratories is recalling seven lots of Perrigo Clindamycin Palmitate Hydrochloride for Oral Solution due to the presence of particulate matter.

    Product
    Perrigo, Clindamycin Palmitate Hydrochloride for Oral Solution, USP, 75mg/5mL, 100 ml, NDC 0574-0129-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1147-2014·2014-03-12

    Hospira Recalls Bupivacaine Hydrochloride Vials Due to Particulate Matter

    Hospira Inc. is recalling 115,500 vials of Bupivacaine Hydrochloride injection due to a confirmed report of visible particulate matter embedded in the glass vials.

    Product
    BUPIVACAINE HYDROCHLORIDE — BUPIVACAINE HYDROCHLORIDE (BUPIVACAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1054-2014·2014-02-12

    B. Braun Recalls Cefepime Injection Due to Visible Organic Particulate Matter

    B. Braun Medical Inc. is recalling 18,936 containers of Cefepime Hydrochloride and Dextrose Injection due to the presence of visible organic particulate matter.

    Product
    CEFEPIME HYDROCHLORIDE AND DEXTROSE — CEFEPIME HYDROCHLORIDE AND DEXTROSE (CEFEPIME HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1057-2014·2014-02-12

    Baxter Recalls Nitroglycerin Injection Due to Particulate Matter

    Baxter Healthcare is recalling 49,932 vials of Nitroglycerin in Dextrose Injection because particulate matter was found in one vial.

    Product
    NITROGLYCERIN IN DEXTROSE — NITROGLYCERIN IN DEXTROSE (NITROGLYCERIN)
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1049-2014·2014-02-05

    Alexion Recalls Soliris Vials Due to Visible Particulate Matter

    Alexion Pharmaceuticals is recalling 21,661 vials of Soliris (eculizumab) because they failed an appearance test for visible particles.

    Product
    SOLIRIS — SOLIRIS (ECULIZUMAB)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1034-2014·2014-01-29

    Fresenius Kabi Recalls Tranexamic Acid Injection Due to Particulate Matter

    Fresenius Kabi USA is recalling 121,456 vials of Tranexamic Acid Injection USP due to the presence of particulate matter consistent with glass vial delamination.

    Product
    Tranexamic Acid Injection USP, 1000mg/10mL, 10mL vial, Rx only. Mfd by: Fresenius Kabi USA, LLC Packaged under two labels: 1) Mfd for: APP Pharmaceuticals, LLC; Schaumburg, IL 60173, NDC 63323-563-10, and 2) Mfd in USA; for Nexus Pharmaceuticals Inc; Vernon Hills, IL 60061. N
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-380-2014·2013-12-25

    Hospira Recalls Bupivacaine Hydrochloride Injection Due to Particulate Matter

    Hospira Inc. is recalling 118,100 vials of 0.25% Bupivacaine Hydrochloride Injection due to the presence of visible particulate matter.

    Product
    BUPIVACAINE HYDROCHLORIDE — BUPIVACAINE HYDROCHLORIDE (BUPIVACAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-381-2014·2013-12-25

    Hospira Recalls Bupivacaine Hydrochloride Injection Due to Particulate Matter

    Hospira Inc. is recalling 119,600 vials of Bupivacaine Hydrochloride Injection due to the presence of visible particulate matter.

    Product
    BUPIVACAINE HYDROCHLORIDE — BUPIVACAINE HYDROCHLORIDE (BUPIVACAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-001-2014·2013-11-27

    Teva Recalls Copaxone Syringes Due to Foreign Particulate Matter

    Teva Pharmaceuticals is recalling 6,803 cartons of Copaxone pre-filled syringes because a foreign particle was found in one unit.

    Product
    COPAXONE — COPAXONE (GLATIRAMER ACETATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-0196-2014·2013-11-20

    Terumo Recalls Sarns Venous Return Cannulae Due to Particulate

    Terumo CVS is recalling Sarns Venous Return Cannulae because in-process inspections found loose fiber particulate exceeding specifications.

    Product
    Sarns" Venous Return Cannulae, 20 Fr with 1/4" flare, 14.5" (37 cm) long. Indicated for venous drainage during cardiopulmonary bypass surgery for dial cannulation of the superior and inferior vena cava.
    Category
    Medical Device
    Distribution
    9 states
  • SevereFDA (Drugs)·D-66318-001·2013-11-13

    Amgen Recalls Prolia Injection Due to Visible Cellulose Fibers

    Amgen is recalling 4,163 Prolia (denosumab) prefilled syringes because visible cellulose fibers were found during routine quality checks.

    Product
    PROLIA — PROLIA (DENOSUMAB)
    Category
    Drug
    Distribution
    Distributed nationwide